THIS REORGANIZATION SETTLEMENT AGREEMENT (hereinafter referred to as the “Agreement”) is made as of the 14 day of October, 2016. B E T W E E N:Reorganization Settlement Agreement • November 18th, 2016 • Eastgate Biotech Corp • Investors, nec
Contract Type FiledNovember 18th, 2016 Company IndustryEASTGATE BIOTECH CORP., a corporation incorporated pursuant to the laws of the State of Nevada, in the United States of America.
ASSIGNMENT AGREEMENTAssignment Agreement • November 18th, 2016 • Eastgate Biotech Corp • Investors, nec • Ontario
Contract Type FiledNovember 18th, 2016 Company Industry JurisdictionThis Assignment Agreement (this “Agreement”) is entered into as of October 28, 2014 (the “Effective Date”) by and among Eastgate Pharmaceuticals Inc., a company organized and existing under the laws of the province of Ontario, Canada (“Assignee”), Joseph Schwarz, an individual (“JS”), and Michael Weisspapir, an individual (“MW”), together the “Assignors”).